{"sourcedb":"DevicePMAs@therightstef","sourceid":"P150025_S000","text":"Approval for the pd-l1 ihc 28-8 pharmdx. this device is indicated for the following: 1) pd-l1 ihc 28-8 pharmdx is a qualitative immunohisto-chemical assay using monoclonal rabbit anti-pd-l1, clone 28-8 intended for use in the detection of pd-l1 protein in formalin-fixed, paraffin-embedded (ffpe) non-squamous non-small cell lung cancer (nsclc) tissue using envision flex visualization system on autostainer link 48; 2) pd-l1 protein expression is defined as the percentage of tumor cells exhibiting positive membrane staining at any intensity; and3) pd-l1 expression as detected by pd-l1 ihc 28-8 pharmdx in non-squamous nsclc may be associated with enhanced survival from opdivo  (nivolumab).","project":"consensus_PMA_Age_Indications"}